AAAAAA
Results:
1-21
|
Results: 21
Authors:
Dubuc, M
Khairy, P
Rodriguez-Santiago, A
Talajic, M
Tardif, JC
Thibault, B
Roy, D
Citation: M. Dubuc et al., Catheter cryoablation of the atrioventricular node in patients with atrialfibrillation: A novel technology for ablation of cardiac arrhythmias, J CARD ELEC, 12(4), 2001, pp. 439-444
Authors:
Wyse, DG
Talajic, M
Hafley, GE
Buxton, AE
Mitchell, LB
Kus, TK
Packer, DL
Kou, WH
Lemery, R
Santucci, P
Grimes, D
Hickey, K
Stevens, C
Singh, SN
Citation: Dg. Wyse et al., Antiarrhythmic drug therapy in the Multicenter UnSustained Tachycardia Trial (MUSTT): Drug testing and as-treated analysis, J AM COL C, 38(2), 2001, pp. 344-351
Authors:
Khairy, P
Talajic, M
Dominguez, M
Tardif, JC
Juneau, M
Lavoie, L
Roy, D
Dubuc, M
Citation: P. Khairy et al., Atrioventricular interval optimization and exercise tolerance, PACE, 24(10), 2001, pp. 1534-1540
Authors:
Tang, ASL
Roberts, RS
Kerr, C
Gillis, AM
Green, MS
Talajic, M
Yusuf, S
Abdollah, H
Gent, M
Connolly, SJ
Citation: Asl. Tang et al., Relationship between pacemaker dependency and the effect of pacing mode oncardiovascular outcomes, CIRCULATION, 103(25), 2001, pp. 3081-3085
Authors:
Humphries, KH
Kerr, CR
Connolly, SJ
Klein, G
Boone, JA
Green, M
Sheldon, R
Talajic, M
Dorian, P
Newman, D
Citation: Kh. Humphries et al., New-onset atrial fibrillation - Sex differences in presentation, treatment, and outcome, CIRCULATION, 103(19), 2001, pp. 2365-2370
Authors:
Derakhchan, K
Villemaire, C
Talajic, M
Nattel, S
Citation: K. Derakhchan et al., The class III antiarrhythmic drugs dofetilide and sotalol prevent AF induction by atrial premature complexes at doses that fail to terminate AF, CARDIO RES, 50(1), 2001, pp. 75-84
Authors:
Connolly, SJ
Talajic, M
Citation: Sj. Connolly et M. Talajic, Canadian Cardiovascular Society 1999 consensus conference on prevention ofsudden death from ventricular arrhythmia, CAN J CARD, 16, 2000, pp. 8C-9C
Authors:
Talajic, M
Mitchell, LB
Hadjis, T
Citation: M. Talajic et al., The role of prophylactic implantable cardioverter defibrillators to prevent sudden cardiac death, CAN J CARD, 16, 2000, pp. 26C-28C
Authors:
Connolly, SJ
Talajic, M
Citation: Sj. Connolly et M. Talajic, Summary of the CCS Consensus Conference on Prevention of Sudden Death fromCardiac Arrhythmia, CAN J CARD, 16(10), 2000, pp. 1298-1302
Authors:
Talajic, M
Roy, D
Lambert, J
Citation: M. Talajic et al., Amiodarone to prevent recurrence of atrial fibrillation - Reply, N ENG J MED, 343(8), 2000, pp. 579-580
Authors:
Buxton, AE
Lee, KL
DiCarlo, L
Gold, MR
Greer, GS
Prystowsky, EN
O'Toole, MF
Tang, A
Fisher, JD
Coromilas, J
Talajic, M
Hafley, G
Citation: Ae. Buxton et al., Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death, N ENG J MED, 342(26), 2000, pp. 1937-1945
Authors:
Connolly, SJ
Kerr, CR
Gent, M
Roberts, RS
Yusuf, S
Gillis, AM
Sami, MH
Talajic, M
Tang, ASL
Klein, GJ
Lau, C
Newman, DM
Citation: Sj. Connolly et al., Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes, N ENG J MED, 342(19), 2000, pp. 1385-1391
Authors:
Roy, D
Talajic, M
Dorian, P
Connolly, S
Eisenberg, MJ
Green, M
Kus, T
Lambert, J
Dubuc, M
Gagne, P
Nattel, S
Thibault, B
Citation: D. Roy et al., Amiodarone to prevent recurrence of atrial fibrillation, N ENG J MED, 342(13), 2000, pp. 913-920
Authors:
Frasure-Smith, N
Lesperance, F
Gravel, G
Masson, A
Juneau, M
Talajic, M
Bourassa, MG
Citation: N. Frasure-smith et al., Depression and health-care costs during the first year following myocardial infarction, J PSYCHOSOM, 48(4-5), 2000, pp. 471-478
Authors:
Skanes, AC
Dubuc, M
Klein, GJ
Thibault, B
Krahn, AD
Yee, R
Roy, D
Guerra, P
Talajic, M
Citation: Ac. Skanes et al., Cryothermal ablation of the slow pathway for the elimination of atrioventricular nodal reentrant tachycardia, CIRCULATION, 102(23), 2000, pp. 2856-2860
Authors:
Frasure-Smith, N
Lesperance, F
Gravel, G
Masson, A
Juneau, M
Talajic, M
Bourassa, MG
Citation: N. Frasure-smith et al., Social support, depression, and mortality during the first year after myocardial infarction, CIRCULATION, 101(16), 2000, pp. 1919-1924
Authors:
Paquette, M
Roy, D
Talajic, M
Newman, D
Couturier, A
Yang, C
Dorian, P
Citation: M. Paquette et al., Role of gender and personality on quality-of-life impairment in intermittent atrial fibrillation, AM J CARD, 86(7), 2000, pp. 764-768
Authors:
Dubuc, M
Roy, D
Thibault, B
Ducharme, A
Tardif, JC
Villemaire, C
Leung, TK
Talajic, M
Citation: M. Dubuc et al., Transvenous catheter ice mapping and cryoablation of the atrioventricular node in dogs, PACE, 22(10), 1999, pp. 1488-1498
Authors:
Frasure-Smith, N
Lesperance, F
Juneau, M
Talajic, M
Bourassa, MG
Citation: N. Frasure-smith et al., Gender, depression, and one-year prognosis after myocardial infarction, PSYCHOS MED, 61(1), 1999, pp. 26-37
Authors:
Geelen, P
O'Hara, GE
Roy, N
Talajic, M
Roy, D
Plante, S
Turgeon, J
Citation: P. Geelen et al., Comparison of propafenone versus procainamide for the acute treatment of atrial fibrillation after cardiac surgery, AM J CARD, 84(3), 1999, pp. 345
Authors:
Dubuc, M
Talajic, M
Roy, D
Thibault, B
Leung, TK
Friedman, PL
Citation: M. Dubuc et al., Feasibility of cardiac cryoablation using a transvenous steerable electrode catheter, J INTERV C, 2(3), 1998, pp. 285-292
Risultati:
1-21
|